Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Epstein-Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes.

Ceccarelli S, Visco V, Raffa S, Wakisaka N, Pagano JS, Torrisi MR.

Int J Cancer. 2007 Oct 1;121(7):1494-506.

2.

Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.

Wakisaka N, Murono S, Yoshizaki T, Furukawa M, Pagano JS.

Cancer Res. 2002 Nov 1;62(21):6337-44.

3.

Tetraspanin CD63 Bridges Autophagic and Endosomal Processes To Regulate Exosomal Secretion and Intracellular Signaling of Epstein-Barr Virus LMP1

Hurwitz SN, Cheerathodi MR, Nkosi D, York SB, Meckes DG Jr.

J Virol. 2018 Feb 12;92(5). pii: e01969-17. doi: 10.1128/JVI.01969-17. Print 2018 Mar 1.

4.

CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling.

Hurwitz SN, Nkosi D, Conlon MM, York SB, Liu X, Tremblay DC, Meckes DG Jr.

J Virol. 2017 Feb 14;91(5). pii: e02251-16. doi: 10.1128/JVI.02251-16. Print 2017 Mar 1.

5.

Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9.

Keryer-Bibens C, Pioche-Durieu C, Villemant C, Souquère S, Nishi N, Hirashima M, Middeldorp J, Busson P.

BMC Cancer. 2006 Dec 8;6:283.

6.

LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation.

Verweij FJ, van Eijndhoven MA, Hopmans ES, Vendrig T, Wurdinger T, Cahir-McFarland E, Kieff E, Geerts D, van der Kant R, Neefjes J, Middeldorp JM, Pegtel DM.

EMBO J. 2011 Jun 1;30(11):2115-29. doi: 10.1038/emboj.2011.123. Epub 2011 Apr 28.

7.
8.

Exosomal sorting of the viral oncoprotein LMP1 is restrained by TRAF2 association at signalling endosomes.

Verweij FJ, de Heus C, Kroeze S, Cai H, Kieff E, Piersma SR, Jimenez CR, Middeldorp JM, Pegtel DM.

J Extracell Vesicles. 2015 Apr 10;4:26334. doi: 10.3402/jev.v4.26334. eCollection 2015.

9.

Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.

Tao YG, Tan YN, Liu YP, Song X, Zeng L, Gu HH, Tang M, Li W, Yi W, Cao Y.

Cell Signal. 2004 Jul;16(7):781-90.

PMID:
15115657
10.

Transmembrane Domains Mediate Intra- and Extracellular Trafficking of Epstein-Barr Virus Latent Membrane Protein 1.

Nkosi D, Howell LA, Cheerathodi MR, Hurwitz SN, Tremblay DC, Liu X, Meckes DG Jr.

J Virol. 2018 Aug 16;92(17). pii: e00280-18. doi: 10.1128/JVI.00280-18. Print 2018 Sep 1.

PMID:
29950415
11.

Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.

Terrin L, Dal Col J, Rampazzo E, Zancai P, Pedrotti M, Ammirabile G, Bergamin S, Rizzo S, Dolcetti R, De Rossi A.

J Virol. 2008 Oct;82(20):10175-87. doi: 10.1128/JVI.00321-08. Epub 2008 Aug 6.

12.

Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5.

Ohtani N, Brennan P, Gaubatz S, Sanij E, Hertzog P, Wolvetang E, Ghysdael J, Rowe M, Hara E.

J Cell Biol. 2003 Jul 21;162(2):173-83. Epub 2003 Jul 14.

13.

Epstein-Barr virus induces invasion and metastasis factors.

Wakisaka N, Pagano JS.

Anticancer Res. 2003 May-Jun;23(3A):2133-8. Review.

PMID:
12894587
15.

Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.

Larcher C, Bernhard D, Schaadt E, Adler B, Ausserlechner MJ, Mitterer M, Huemer HP.

Haematologica. 2003 Dec;88(12):1324-35.

16.

The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.

Nakamura H, Ishii C, Suehiro M, Iguchi A, Kuroda K, Shimizu K, Shimizu N, Imadome K, Yajima M, Fujiwara S.

Virus Res. 2008 Feb;131(2):170-9. Epub 2007 Oct 25.

PMID:
17963943
17.

A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.

Adriaenssens E, Mougel A, Goormachtigh G, Loing E, Fafeur V, Auriault C, Coll J.

Oncogene. 2004 Apr 8;23(15):2681-93. Erratum in: Oncogene. 2004 Oct 21;23(49):8184.

PMID:
14767477
18.

The interactome of EBV LMP1 evaluated by proximity-based BioID approach.

Rider MA, Cheerathodi MR, Hurwitz SN, Nkosi D, Howell LA, Tremblay DC, Liu X, Zhu F, Meckes DG Jr.

Virology. 2018 Mar;516:55-70. doi: 10.1016/j.virol.2017.12.033. Epub 2018 Jan 9.

PMID:
29329079
19.
20.

PRA1 promotes the intracellular trafficking and NF-kappaB signaling of EBV latent membrane protein 1.

Liu HP, Wu CC, Chang YS.

EMBO J. 2006 Sep 6;25(17):4120-30. Epub 2006 Aug 17.

Supplemental Content

Support Center